GABELLI FUNDS LLC - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 154 filers reported holding WUXI PHARMATECH CAYMAN INC in Q2 2015. The put-call ratio across all filers is 3.79 and the average weighting 0.4%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$5,099,000
+32.6%
118,000
+29.7%
0.03%
+50.0%
Q2 2015$3,846,000
+9.0%
91,0000.0%0.02%
+11.1%
Q1 2015$3,529,000
+15.2%
91,0000.0%0.02%
+20.0%
Q4 2014$3,064,000
-1.7%
91,000
+2.2%
0.02%
-6.2%
Q3 2014$3,117,000
+10.3%
89,000
+3.5%
0.02%
+14.3%
Q2 2014$2,826,000
-10.9%
86,0000.0%0.01%
-12.5%
Q1 2014$3,170,000
-12.1%
86,000
-8.5%
0.02%
-15.8%
Q4 2013$3,608,000
-21.9%
94,000
-44.2%
0.02%
-26.9%
Q3 2013$4,617,000
-20.8%
168,500
-39.3%
0.03%
-25.7%
Q2 2013$5,831,000277,6480.04%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q2 2015
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 448,361$15,096,00021.12%
Sloane Robinson LLP 107,400$3,616,0006.28%
Sensato Investors LLC 327,754$11,035,0003.26%
Grandeur Peak Global Advisors, LLC 388,810$13,091,0002.94%
GRATRY & Co LLC 205,800$7,899,0002.59%
THOMAS WHITE INTERNATIONAL LTD 464,926$15,654,0002.15%
COMGEST GLOBAL INVESTORS S.A.S. 1,819,980$61,279,0001.87%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,169,686$39,383,0001.64%
Ninety One North America, Inc. 133,372$4,491,0001.32%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 87,560$2,948,0001.27%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders